Relvar Ellipta 92/22 mcg, Einzeldosiertes Pulver zur Inhalation
7680629690016
CH-62969
Einzeldosiertes Pulver zur Inhalation
Associated product:
RELVAR ELLIPTA pdr inh 92mcg/22mcg 30 dos
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Einzeldose(n)
- Galenic form
- Einzeldosiertes Pulver zur Inhalation
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
92.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
22.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 49.75
Specialties list
Yes
Generic
No
SL addition date:
01/02/2014
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 62969
- Drug name
- Relvar Ellipta, Einzeldosiertes Pulver zur Inhalation
- Galenic form
- PULIN
- ATC Code
- R03AK10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 09/01/2014
- Authorization expiration date
- 31/12/9999
- IT Number
- 03.04.3.
- Domain
- Human medicine
Package details
- Description (FR)
- RELVAR ELLIPTA pdr inh 92mcg/22mcg 30 dos
- Description (DE)
- RELVAR ELLIPTA Inh Plv 92mcg/22mcg 30 Dos
- Market launch
- 09/01/2014
- Narcotic (BTM)
- No